Additional markers that may be helpful for MRD assessment include CD99, which may be overexpressed in T-lymphoblastic leukemia/lymphoma compared with normal T cells, and CD48, which exhibits reduced expression in T-lymphoblastic leukemia/lymphoma compared with normal T cells [35,36,37]. The gene discussed is CD99; the disease is lymphoma.